2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
EMPAG Posters 0<br />
EP13.2<br />
Decision making dilemmas for E-cadherin mutation carriers: A<br />
family case study<br />
S. C. Downing;<br />
Department <strong>of</strong> Medical <strong>Genetics</strong>, Addenbrookes Hospital, Cambridge, United<br />
Kingdom.<br />
This case study presents two siblings, whose health beliefs, career and<br />
family responsibility had a strong influence on how they perceived their<br />
risk, management choices and decisions . Both were carriers <strong>of</strong> an Ecadherin<br />
(CDH1) mutation and chose to manage their risks differently .<br />
Gastric cancer affects 15 per 100,000 people in the UK and around 3%<br />
arise from a clearly identified inherited gastric cancer predisposition.<br />
One third <strong>of</strong> families with a strong history <strong>of</strong> diffuse gastric cancer have<br />
germ line mutations in the E-cadherin gene . Mutation carriers have a<br />
70-80% life time risk <strong>of</strong> developing gastric cancer with associated poor<br />
outcome, they also have an increased risk <strong>of</strong> lobular breast cancer<br />
and colon cancer . Predictive testing is available for individuals where<br />
a familial mutation has been identified. A positive result provides challenging<br />
decisions regarding personal risk management with the option<br />
<strong>of</strong> endoscopic screening or prophylactic gastrectomy . Screening is unproven<br />
and there is concern that early cancer may be missed since it<br />
is submucosal . The alternative option <strong>of</strong> surgery carries a high morbidity<br />
with life long adaptations required; limited data exists on the outcome<br />
for prophylactic gastrectomy . One sibling opted for preventative<br />
surgery, the other endoscopy screening . Counselling issues included:<br />
career changes, family dynamics, psychosocial aspects, coping with<br />
major surgery, and quality <strong>of</strong> life . Management <strong>of</strong> cancer risk is a personal<br />
issue, risk management options should be explored in depth to<br />
enable the individual to make fully informed decisions .<br />
EP13.3<br />
Quality <strong>of</strong> life in adults with familial adenomatous polyposis<br />
(FAP)<br />
K. Fritzell 1 , J. Björk 1 , M. Arman 2 , R. Hultcrantz 1 , L. Wettergren 2 ;<br />
1 The Swedish Polyposis Registry, Stockholm, Sweden, 2 Department <strong>of</strong> Neurobiology,<br />
Care Sciences and <strong>Society</strong>, Karolinska Institutet, Stockholm, Sweden.<br />
Background: FAP is a disease which among other symptoms is manifested<br />
as multiple polyposis with adenomas in the large intestine, rectum<br />
and duodenum . These adenomas are very likely to turn cancerous<br />
over time . The disease is inherited autosomal dominant . Surgery is<br />
the only treatment that can prevent colorectal cancer and prophylactic<br />
surgery is performed on all patients . Preoperative symptoms are rare,<br />
but a large number <strong>of</strong> patients report functional impairments after surgery<br />
.<br />
Aim: The aim <strong>of</strong> the study was to describe how adult patients with FAP<br />
perceive that the disease has affected their life .<br />
Method: Adult patients (≥20 years) attending the outpatient clinic at<br />
The Swedish Polyposis Registry were invited to participate in focus<br />
group interviews (n=43) . Three focus group interviews were conducted<br />
. Data was analysed by means <strong>of</strong> content analysis .<br />
Results: The content analysis revealed nine themes: Worries and concerns,<br />
Social life, Choice <strong>of</strong> career and education, Risk <strong>of</strong> giving the<br />
disease to the children, Changed food and toilet habits, Experiences<br />
<strong>of</strong> endoscopic examinations, Relationships to health care providers,<br />
Stories about hospital stay at their first surgery, Knowledge <strong>of</strong> FAP.<br />
Conclusion: The study has highlighted several issues <strong>of</strong> concerns related<br />
to FAP . Worries about getting worse due to the disease were expressed<br />
by many <strong>of</strong> the participants but not anyone mentioned cancer<br />
as a threat for future health . Due to the heredity <strong>of</strong> the disease, having<br />
own children or not was a deep and complex question and the discussion<br />
gave an impression <strong>of</strong> a need to defend one’s standpoint .<br />
EP13.4<br />
Participation in Huntington‘s disease research:hoping, coping<br />
and a nice day out<br />
J. Needs;<br />
Cardiff University, Cardiff, United Kingdom.<br />
This poster is based on an ongoing PhD examining Huntington’s disease<br />
(HD) as a case study <strong>of</strong> how the development <strong>of</strong> genetic technologies<br />
and identification <strong>of</strong> human genetic mutations, affect the work <strong>of</strong><br />
the clinic and the lives <strong>of</strong> patients . Ethnographic data from neurological<br />
research clinics (n=11) will be used to explore the current nature and<br />
structure <strong>of</strong> clinical work itself, and will illustrate how different mean-<br />
ings <strong>of</strong> the clinic are enacted by the participants, including patients,<br />
family members, carers, and researchers . This work will be used to inform<br />
later stages <strong>of</strong> the PhD, which will include interviews with patients<br />
and clinical teams and the examination <strong>of</strong> an archive <strong>of</strong> HD patient<br />
records from the 1970’sto the present day .<br />
Current clinical practice emphasises genetic, biological, cognitive and<br />
physical measurement . These are areas associated with neuroscientific<br />
research programmes, and patient recruitment is crucial in order<br />
to provide large data sets for possible future clinical trials . These data<br />
sets will be kept indefinitely and provide material for international collaborative<br />
research . However, for patients and families, research involvement<br />
is not always the focus . Rather, they view participation as a<br />
privileged medical appointment and a way <strong>of</strong> getting answers to their<br />
own situations . They hope for effective treatment via research (stem<br />
cells) and participation may provide one strategy for coping with the<br />
effects <strong>of</strong> the disease . The research environment and relationships<br />
with researchers at repeated clinic visits also provides familiarity and a<br />
social aspect to the whole process, in effect, a nice day out .<br />
EP13.5<br />
Consensus document on best care in HD: a training/educational<br />
program for italian neurologists<br />
G. Jacopini 1 , P. Zinzi 1 , A. R. Bentivoglio 2 , M. Frontali 3 ;<br />
1 ISTC/National Research Council, Rome, Italy, 2 Istituto di Neurologia Università<br />
Cattolica del Sacro Cuore, Policlinico “A.Gemelli”, Rome, Italy, 3 INMM/National<br />
Research Council, Rome, Italy.<br />
Huntington’s disease is a rare, complex, hereditary disorder, characterized<br />
by motor as well as psychiatric symptoms; very <strong>of</strong>ten, neurologists<br />
are unable to handle these patients, lacking guidelines about the<br />
most appropriate way <strong>of</strong> care for them . In July 2007, upon request<br />
<strong>of</strong> the Italian Association for Huntington’s Chorea (A .I .C .H-Rome and<br />
A .I .C .H-Milan), our research group organized a multidisciplinary panel<br />
<strong>of</strong> experts with the main task <strong>of</strong> providing recommendations for the<br />
best care in HD . The panel produced a “consensus document” with recommendations<br />
which address HD patients and families’ main needs,<br />
combining together scientific information and long lasting clinical experience<br />
. The document covers multiple aspects: making the diagnosis<br />
and communicating it, therapeutic management and paramedical<br />
treatments, nutrition and dietary supplements, genetic risk and genetic<br />
testing protocol, co-morbidity, palliative and end-<strong>of</strong>-life care, non medical<br />
support, indications for referral .<br />
The document, written in a synthetic style, contains practical recommendations<br />
aimed at minimize inappropriate care and introducing research<br />
findings into clinical practice <strong>of</strong> neurologists not familiar with<br />
HD issues . The document will be printed (10 .000 copies) and, starting<br />
May <strong>2008</strong>, first introduced in the course <strong>of</strong> three main educational<br />
events (in Northern, Central and Southern Italy) for neurologists . Then<br />
the document will be delivered to 3,500 neurologists working both in<br />
public health care settings and in the private field. In the future we plan<br />
to assess the impact <strong>of</strong> the document through meaningful and measurable<br />
outcomes .<br />
EP13.6<br />
Living with a person with Huntington‘s disease<br />
A. J. A. G. Van Tongerloo, A. M. J. J. De Paepe;<br />
University Hospital Gent, Gent, Belgium.<br />
Introduction: Huntington’s disease, an autosomal dominant neurodegenerative<br />
disorder, is characterized by a triad <strong>of</strong> progressive motor,<br />
cognitive and emotional symptoms . In 1994, predictive testing through<br />
the direct DNA test became available . The psychological impact <strong>of</strong> carriership<br />
on the testee and his/her partner has been extensively evaluated<br />
and reviewed . Few studies however, have been conducted to<br />
explore how living with a person with the disease affects the healthy<br />
partner’s daily life .<br />
Materials and Methods: In January <strong>2008</strong>, a qualitative study was set<br />
up, in which partners <strong>of</strong> persons with HD are questioned through a<br />
semi-structured interview . Topics that are questioned are: coping with<br />
the partner’s symptoms, the symptoms that are the most difficult to<br />
deal with, the changes in personal life <strong>of</strong> the healthy partner, and the<br />
future perspectives for the healthy partners . Furthermore, participants<br />
are asked about their feelings towards their partner, and about communication<br />
on the disease with the affected partner, with their children<br />
and with significant others.